Concentrix Corporation (CNXC)
Return on equity (ROE)
Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 278,074 | 313,842 | 349,299 | 378,354 | 412,646 | 435,049 | 454,213 | 457,277 | 427,039 | 405,577 | |||
Total stockholders’ equity | US$ in thousands | 4,101,640 | 4,143,290 | 2,903,520 | 2,854,260 | 2,800,500 | 2,695,900 | 2,646,630 | 2,723,940 | 2,732,000 | 2,620,260 | 2,565,760 | 2,529,770 | 2,389,280 |
ROE | 6.78% | 7.57% | 12.03% | 13.26% | 14.73% | 16.14% | 17.16% | 16.79% | 15.63% | 15.48% |
February 29, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $278,074K ÷ $4,101,640K
= 6.78%
Concentrix Corporation's return on equity (ROE) has exhibited a decreasing trend over the most recent financial periods. The ROE declined from 15.48% in November 2021 to 6.78% by February 2024. This indicates that the company's ability to generate profits from shareholders' equity has weakened over time. The ROE values fluctuated between 6.78% and 17.16% during the period under review but generally showed a downward trajectory. It is essential for Concentrix Corporation to closely examine the factors contributing to this decline in ROE and take necessary measures to improve its profitability relative to shareholders' equity.
Peer comparison
Feb 29, 2024